ASTERDM - Technical Analysis with Chart Patterns & Indicators
← Back to ListKey Parameters
⭐ Technical Rating: 3.2
✅ Positive
The stock has shown a strong upward trend over the past quarter, evidenced by the significant increase in PAT from 58.9 Cr to 85.3 Cr. Furthermore, the current price is above key moving averages and RSI indicates moderate buying interest.
⚠️ Limitation
The high P/E ratio of 218 suggests overvaluation relative to its peers within the industry, alongside a relatively high PEG ratio of 9.21. This could indicate future growth expectations are priced in too aggressively.
📉 Company Negative News
Recent news reports indicate a decrease in FII holdings, suggesting potential waning institutional investor confidence which may weigh on the stock price.
📈 Company Positive News
The company's quarterly earnings have significantly increased (3.43%) highlighting improved operational performance and profitability compared to the previous quarter.
🏭 Industry
The healthcare sector is currently experiencing growth driven by increasing demand for medical services and pharmaceuticals, particularly in emerging markets where Aster DM operates extensively. Competition within this sector can be intense.
🧾 Conclusion
An entry zone could be established between 810 ₹ - 825 ₹ based on the support level around the 20 DMA and recent price action. A stop-loss order should be placed at 790 ₹ to manage risk, given the high P/E ratio. Overall, while exhibiting positive momentum, investors should exercise caution due to valuation concerns.